Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Am J Surg Pathol. 2008 Mar;32(3):345-53. doi: 10.1097/PAS.0b013e3181592201.

Laminin 5 expression in metaplastic breast carcinomas.

Author information

  • 1The Department of Pathology and Laboratory Medicine, The University of California, Orange, CA 92868, USA. pmcarpen@uci.edu

Erratum in

  • Am J Surg Pathol. 2009 Feb;33(2):322.

Abstract

Metaplastic carcinoma of the breast shows squamous, sarcomatous, or chondromatous differentiation and has a poor prognosis. Laminin 5 is a heterotrimer of alpha3, beta3, and gamma(2) [corrected] chains and induces aggressive properties in cancer cells including motility, invasion, and epithelial to mesenchymal transition. Twenty-five cases included 7 squamous, 4 sarcomatous, 8 chondroid, 1 fibromatosislike metaplastic carcinomas, and 5 cases with 2 metaplastic components. Tumors were stained with laminin 5-specific beta3 and gamma(2) [corrected] chain, p63, and cytokeratin 5/6 (CK 5/6) antibodies. All 4 antibodies stained normal myoepithelium. Both laminin 5 antibodies stained 24/25 (96%) of the tumors, with an identical distribution of the 2 chains in 87.5% of the positively staining cases. In contrast, p63 and CK 5/6 stained 68% and 64% of the tumors, respectively. By comparison, only 16% of high-grade carcinoma controls stained for laminin 5. Similar to the metaplastic carcinomas, all 12 triple negative tumors, those negative for estrogen receptor, progesterone receptor, and Her2/neu, expressed laminin 5. None of 4 breast sarcomas stained for either of the laminin 5 chains or CK 5/6, but 1 (25%) stained for p63. Laminin 5 expression in metaplastic and other basal-like carcinomas is of interest for several reasons. First, these data provide additional evidence of the myoepithelial and basal-like phenotype of these carcinomas. Second, these are the only breast carcinoma subtypes to demonstrate laminin 5 staining in a large proportion of cases. Third, expression of laminin 5 in metaplastic carcinomas may suggest a mechanism for their increased aggressiveness and epithelial to mesenchymal transition phenotype. Finally, compared with other myoepithelial markers, laminin 5 is more sensitive than those previously published. Thus laminin 5 may be helpful for making the diagnosis of metaplastic carcinomas in biopsies, allowing the potential for aggressive early treatment. Further study of other basal-like tumors for laminin 5 expression is warranted to determine the usefulness of laminin 5 in their diagnosis.

PMID:
18300817
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk